Eiger BioPharmaceuticals Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Eiger BioPharmaceuticals Inc.

Eiger BioPharmaceuticals Inc. | Key People and Executives

David A. Cory

President, Chief Executive Officer & Director

David Apelian

COO, Director & Executive Medical Officer

Thomas John Dietz

Independent Chairman

Eldon C. Mayer

Independent Director

Evan Loh

Independent Director

Jeffrey S. Glenn

Independent Director

David A. Cory

President, Chief Executive Officer & Director

David Apelian

COO, Director & Executive Medical Officer

James H. Welch

Chief Financial Officer

Lisa E. Porter

Chief Medical Officer

Debra A. Odink

Senior Vice President-Technical Operations

James P. Shaffer

Chief Business Officer

Ingrid C. Choong

Head-Investor Relations

Thomas John Dietz

Independent Chairman

Eldon C. Mayer

Independent Director

Evan Loh

Independent Director

Jeffrey S. Glenn

Independent Director

View Profile

Address	2155 Park Boulevard Palo Alto California 94306 United States
Employees	-
Website	http://www.eigerbio.com
Updated	07/08/2019
Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for orphan diseases. It focuses on product candidates for the treatment of orphan diseases such as Sarasar, Pegylated Interferon Lambda, Exendin 9-39, and Ubenimex. The company was founded by David A.